Skip to content

Risk assessment of pulmonary hypertension caused by fibrosing mediastinitis

Risk assessment of pulmonary hypertension caused by fibrosing mediastinitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074549
Enrollment
Unknown
Registered
2023-08-09
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibrosing mediastinitis

Interventions

case series:Nil

Sponsors

Gansu Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1)Pulmonary hypertension was diagnosed by right heart catheterization (RHC), defined as mean pulmonary artery pressure (mPAP) > 20mmHg; 2) Chest computed tomography (CT) manifests as focal or diffuse hyperplasia of fibrous tissues compressing adjacent structures (vascular, airway, or esophageal) with or without calcification.

Exclusion criteria

Exclusion criteria: 1) Patients with mediastinal malignancies and/or prior mediastinal radiation therapy; 2) Patients with mediastinal necrotizing granulomatous lymphadenitis, systemic sclerosis, and other diseases that cause hyperplasia of tissues within the mediastinum; 3) mean pulmonary artery pressure (mPAP) = 20 mmHg by RHC; 4) concomitant with other types of pulmonary hypertension; 5) comprised serious concomitant diseases, or significant impairment of organ function;

Design outcomes

Primary

MeasureTime frame
survival ; pulmonary vascular resistance;

Secondary

MeasureTime frame
mean pulmonary artery pressure;systolic pulmonary artery pressure;diastolic pulmonary artery pressure; cardiac index;mixed venous oxygen saturation;tricuspid annual plane systolic excursion;N-terminal pro-brain natriuretic peptide;World Health Organization Functional Class;6-minute walking distance;right atrial area;

Countries

China

Contacts

Public ContactYunshan Cao

Gansu Provincial Hospital

yunshancao@126.com+86 136 6930 6699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026